2 not yet recruiting, 2 withdrawn, 1 recruiting. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Not yet recruiting 2, Withdrawn 2, Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow oxfendazole: new trials by email Literature Review of oxfendazole trials Research Report on oxfendazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oxfendazole in Mild Parenchymal Brain Cysticercosis Oxfendazole single dose, Oxfendazole three doses, albendazole plus praziquantel regime - Brain Cysticercosis | Phase 2 / Phase 3 | Not yet recruiting | Universidad Peruana Cayetano Heredia | 544 | 2026-12-01 | 2026-05-01 |
| One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis Oxfendazole, Triclabendazole - Fascioliasis | Phase 2 | Not yet recruiting | Universidad Peruana Cayetano Heredia | 336 | 2026-08-15 | 2026-06-03 |
| A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults Albendazole, Oxfendazole - Trichuriasis | Phase 2 | Recruiting | Asociacion Benefica Prisma | 249 | 2024-09-07 | 2026-07-28 |
| Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults Oxfendazole, Albendazole - Trichuris Infection | Phase 2 | Withdrawn | Oxfendazole Development Group | 2024-07-01 | 2026-11-06 | |
| Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults oxfendazole, albendazole - Helminthiasis | Phase 2 | Withdrawn | Johns Hopkins Bloomberg School of Public Health | 2019-11-01 | 2019-08-15 |
Trichuriasis (2) · Cysticercosis (1) · Fascioliasis (1) · Helminthiasis (1) · Hookworm Infections (1) · Neurocysticercosis (1)
Universidad Peruana Cayetano Heredia (2) · Asociacion Benefica Prisma (1) · Johns Hopkins Bloomberg School of Public Health (1) · Oxfendazole Development Group (1)
Peru (1)
Hector H Garcia, MD, PhD (2) · Armando E Gonzalez, DVM, PhD (1) · Hector H Garcia, MD PhD (1) · Lourdes Rodriguez, MD (1) · Maribel Paredes Olortegui, MPH (1) · Miguel M Cabada, MD MSc (1) · Richard J Horton, MB BChir, MRCGP, FFPM (1) · Robert H Gilman, MD (1)
U01AI155323 (1)